For years, veterans with inclusion body myositis have asserted that their disease was caused by exposure to toxic materials while they served in the US armed forces. Members of TMA’s…
Continue Reading
TMA Wins NIH’s Prestigious NOURISH Autoimmunity Challenge
The Myositis Association (TMA) has earned national recognition as one of the winning teams in the National Institutes of Health’s NOURISH (Nutrition for OUR Immune System Health): Autoimmunity Challenge. This…
Continue Reading
The Myositis Agenda on Rare Disease Day 2026
By Paula Eichenbrenner, TMA Executive Director Myositis advocates are gathered on Capitol Hill in Washington, DC to meet with Members of Congress about issues that are incredibly important to our…
Continue Reading
Celebrating Successes at Rare Disease Week 2026
TMA Board of Directors Chair Rich DeAugustinis is leading our delegation of myositis advocates at EveryLife Foundation’s Rare Disease Week, February 24-26, 2026 in Washington, DC. Rare Disease Week brings…
Continue Reading
Update on Abcuro’s MUSCLE Study
Tuesday, February 24, 2026 Today, Abcuro released topline results from their Phase 2/3 MUSCLE study evaluating ulviprubart in patients with inclusion body myositis (IBM). Briefly, the study did not demonstrate…
Continue Reading